C. Almire

TET2 Deficiency Inhibits Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells

E. Solary, W. Vainchenker, N. Debili, 2014, Stem cells.

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.

E. Pronier, E. Solary, W. Vainchenker, 2011, Blood.

PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)‐positive peripheral T‐cell lymphomas

R. Siebert, J. Martín-Subero, H. Tilly, 2007, Genes, chromosomes & cancer.

Clonal analysis of erythroid progenitors suggests that pegylated interferon α-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells

E. Pronier, W. Vainchenker, J. P. Couédic, 2010, Leukemia.

Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis

M. Fontenay, D. Bouscary, O. Kosmider, 2021, Blood Cancer Journal.

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients

M. Fontenay, O. Hermine, V. Asnafi, 2022, Blood Cancer Journal.

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

I. Amit, F. Ginhoux, L. Zitvogel, 2020, Cell.